
How much does the current virus crisis share in common with early HIV outbreak scare?

With fostemsavir now available for patients with few options, an expert discusses what challenges MDR-HIV patients face in their care.

A look at the BRIGHTE study data which evidenced the recently FDA-approved add-on agent.

Carey Hwang, MD, PhD, executive director and product development lead, Global Clinical Development of Infectious Disease at Merck spoke with Contagion® regarding the therapies and went further into depth about the studies.

How the inflammatory-based syndrome is affecting US children during the COVID-19 pandemic.

A discussion on how the pediatric inflammatory syndrome has begun to affect the US months into the pandemic.

A discussion with a Yale expert on what new CDC data shows.

Judith Feinberg, MD, FIDSA, describes ongoing investigation into the immune response from COVID-19.

A brief overview of our top stories.

Jonathan Spero, MD, discusses workplace safety in the time of SARS-CoV-2.

Recent concerns have been raised about a spike protein mutation in SARS-CoV-2. Are these fears grounded?

Judith Feinberg, MD, FIDSA, describes surprising outcomes in many COVID-19 cases among people living with HIV.

The status of emergency departments in the city during the pandemic's migration west.

Bradley Sherman, MD, shares insight as to what goes into a respiratory ventilator recovery unit.

A brief summary of the latest news.

Dr. Luwy Musey, executive director in biologics, Merck Research Laboratories, discusses what clinicians need to know about the latest PCVs.

A look at how the state became a belated hotspot, and what may help reduce future infection growth.

A brief on today's top ID news.

In a joint-interview, we discuss the PCV pipeline with Dr. Luwy Musey (of Merck & Co.) and Dr. Steven Pelton.

Video briefing on the day's top infectious disease news.

Patrick Soon-Shiong, MD, Chairman and CEO of ImmunityBio, explains why the firm's COVID-19 research benefits from drawing on a background in cancer.

An overview of today's top infectious disease stories.

Patrick Soon-Shiong, MD, CEO of ImmunityBio, discusses the pandemic as a unique moment in world & American history.

Thomas File, Jr. MD, MSc, FIDSA, president of the Infectious Diseases Society of America, weighs in on COVID vaccine development, fears of a second wave, and treatment candidates.

A video summary of the latest infectious disease headlines.

A June 19, 2020 recap of the biggest headlines in pandemic research and response.

Steven Woloshin, MD, MS, discusses a recently authored article in the New England Journal of Medicine describing the challenges and implications of false negative tests for SARS-CoV-2 infection.

A video review of the latest ID news.

Vibeke Strand, MD, MACR, FACP, of the Division of Immunology/Rheumatology at Stanford University School of Medicine, discusses ongoing AI research in her field.

An overview of 3 recent infectious disease news stories.